Serum B cell activating factor (BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis-Reference-Cited by-同舟云学术

Serum B cell activating factor (BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis

Published:2022-07-08 Issue:4 Volume:45 Page:238-243
ISSN:2578-5826
Container-title:Immunological Medicine
language:en
Short-container-title:Immunological Medicine

Author:

Tsuboi Kazuyuki¹^ORCID,Noguchi Kazuteru¹,Kitano Masayasu²,Furukawa Tetsuya¹,Hashimoto Teppei¹,Azuma Naoto¹^ORCID,Matsui Kiyoshi¹

Affiliation:

1. Division of Allergology and Rheumatology, Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan

2. Division of Rheumatology, Department of Internal Medicine, Sumitomo Hospital, Nakanoshima, Japan

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/25785826.2022.2094592

Reference20 articles.

1. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis

2. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study

3. Comparison of the Phenotype and Outcome of Granulomatosis with Polyangiitis Between UK and Japanese Cohorts

4. Systematic review and meta-analysis for 2017 clinical practice guidelines of the Japan research committee of the ministry of health, labour, and welfare for intractable vasculitis for the management of ANCA-associated vasculitis

5. Low-dose rituximab as induction therapy for ANCA-associated vasculitis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of BAFF and APRIL receptors on circulating B cells in antineutrophil cytoplasmic antibody-associated vasculitis;Clinical and Experimental Immunology;2023-02-16